CONSETT MEDICAL CENTRE
STATION YARD, CONSETT
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 30 | 39 | 76.9% | |
| HF 4 | 2011 | 31 | 37 | 83.8% | |
| HF 4 | 2012 | 34 | 42 | 81.0% | |
| HF 4 | 2013 | 37 | 45 | 82.2% | |
| HF004 | 2014 | 25 | 30 | 83.3% | |
| HF004 | 2015 | 22 | 24 | 91.7% | |
| HF004 | 2016 | 37 | 39 | 94.9% | |
| HF004 | 2017 | 40 | 41 | 97.6% | |
| HF004 | 2018 | 52 | 56 | 92.9% | |
| HF004 | 2019 | 70 | 74 | 94.6% | |
| HF004 | 2020 | 69 | 78 | 88.5% | |
| HF006 | 2021 | 92 | 103 | 89.3% | |
| HF006 | 2022 | 99 | 105 | 94.3% | |
| HF006 | 2023 | 112 | 112 | 100.0% |
